TWD 8.03
(1.77%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.17 Million TWD | -36.98% |
2022 | 1.85 Million TWD | 461.33% |
2021 | 331 Thousand TWD | -62.81% |
2020 | 890 Thousand TWD | 0.0% |
2019 | 890 Thousand TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 119 Thousand TWD | 591.6% |
2024 Q1 | 119 Thousand TWD | -89.84% |
2023 FY | 1.17 Million TWD | -36.98% |
2023 Q2 | 1.51 Million TWD | 84.2% |
2023 Q1 | 823 Thousand TWD | -55.71% |
2023 Q3 | 472 Thousand TWD | -68.87% |
2023 Q4 | 1.17 Million TWD | 148.09% |
2022 Q4 | 1.85 Million TWD | 58.8% |
2022 Q3 | 1.17 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sagittarius Life Science Corp | 13.32 Million TWD | 91.211% |
Neith Corporation | 3.54 Million TWD | 66.93% |
TaiRx, Inc. | 12.28 Million TWD | 90.469% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 91.056% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -117.658% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 91.854% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 99.709% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 98.791% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 99.544% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 99.587% |
Visgeneer Inc. | 158.6 Million TWD | 99.262% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 99.327% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 78.439% |
Enimmune corporation | 45.73 Million TWD | 97.44% |
EirGenix Inc. | 465.16 Million TWD | 99.748% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 97.988% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 99.701% |
Feng Chi Biotech Corp. | 10.79 Million TWD | 89.155% |
Lukas Biomedical Inc. | 82.55 Million TWD | 98.582% |
RBC Bioscience Corporation | 487.36 Million TWD | 99.76% |
BiOptic Inc. | 93.19 Million TWD | 98.744% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | 15.329% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.828% |
Mycenax Biotech Inc. | 726.27 Million TWD | 99.839% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.941% |
Bio Preventive Medicine Corp. | 113.44 Million TWD | 98.968% |
Level Biotechnology Inc. | 13.5 Million TWD | 91.327% |
TaiMed Biologics Inc. | 750.85 Million TWD | 99.844% |
GlycoNex Incorporation | 900 Thousand TWD | -30.111% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 99.634% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | 44.607% |
Lin BioScience, Inc. | 42.87 Million TWD | 97.269% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | 67.4% |
VBI | - TWD | -Infinity% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -34.598% |
NaviFUS Corp. | 32.69 Million TWD | 96.418% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 99.719% |
Sinew Pharma Inc. | 6.46 Million TWD | 81.884% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 95.682% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 99.403% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 90.714% |
AP Biosciences Inc | 82.07 Million TWD | 98.573% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.96% |
3D Global Biotech Inc. | 10.37 Million TWD | 88.718% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 99.189% |
Intech Biopharm Corporation | 1.43 Billion TWD | 99.918% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.706% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | 73.105% |
TWi Biotechnology, Inc. | 7.97 Million TWD | 85.309% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 80.146% |
TCI GENE Inc. | 6.79 Million TWD | 82.767% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 85.922% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | 87.803% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 99.564% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 89.038% |
PharmaEngine, Inc. | 14.8 Million TWD | 92.093% |
Savior Lifetec Corporation | 270.37 Million TWD | 99.567% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 98.432% |
OBI Pharma, Inc. | 501.05 Million TWD | 99.766% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 96.56% |
Acepodia, Inc. | 273.81 Million TWD | 99.572% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 94.276% |